The global market for Next-generation Sequencing Library Preparation was estimated at US$1.9 Billion in 2024 and is projected to reach US$4.1 Billion by 2030, growing at a CAGR of 13.4% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Next-generation Sequencing Library Preparation market.
Segments: Sequencing Type (Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Other Sequencing Types); Product Type (Library Preparation Reagents & Consumables, Library Preparation Instruments); Application (Drug & Biomarker Discovery Application, Disease Diagnostics Application, Cancer Diagnostics Application, Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications); End-Use (Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use, Other End-Uses)
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
Global Next-Generation Sequencing Library Preparation Market - Key Trends & Drivers Summarized
How Is Next-Generation Sequencing Library Preparation Advancing Genomic Research?
Next-generation sequencing (NGS) library preparation is a critical step in genomic analysis, enabling researchers to convert DNA and RNA samples into formats suitable for high-throughput sequencing. The preparation process involves fragmentation, adapter ligation, amplification, and quality control, ensuring accurate and efficient sequencing. NGS technology has revolutionized genetics, allowing for faster and more cost-effective analysis of genomes, transcriptomes, and epigenomes across various applications, including precision medicine, oncology, infectious disease research, and agricultural genomics. The increasing adoption of NGS in clinical diagnostics is driving demand for more streamlined, automation-friendly, and scalable library preparation kits that enhance efficiency and reproducibility. Additionally, advancements in single-cell sequencing and long-read sequencing are pushing the boundaries of genome analysis, necessitating improved library preparation methods tailored for complex samples. As researchers strive for higher sequencing accuracy, sensitivity, and throughput, library preparation technologies continue to evolve, playing a crucial role in advancing the field of genomics.What Challenges Are Affecting the Adoption of NGS Library Preparation Technologies?
Despite its transformative potential, the NGS library preparation market faces several challenges that impact accessibility, efficiency, and cost-effectiveness. One of the primary concerns is the labor-intensive nature of traditional library preparation methods, which require skilled technicians, expensive reagents, and extensive sample handling. Variability in sample quality and preparation efficiency can lead to sequencing errors and reduced data reliability, necessitating robust quality control measures. Another major challenge is the high cost of library preparation kits, which can be prohibitive for smaller research institutions and clinical laboratories. Additionally, the complexity of handling diverse sample types, including low-input and degraded DNA, requires highly specialized protocols, increasing the need for customized solutions. Regulatory challenges and standardization issues further hinder clinical adoption, as laboratories must adhere to stringent compliance requirements for NGS-based diagnostics. Overcoming these challenges will require continued innovation in automation, reagent chemistry, and bioinformatics solutions to make NGS library preparation more efficient, cost-effective, and scalable for a wider range of applications.How Are Innovations Driving the Future of NGS Library Preparation?
Technological advancements are significantly improving the efficiency and accuracy of NGS library preparation, addressing key challenges in sample processing and sequencing quality. One of the most impactful innovations is the automation of library preparation workflows, reducing hands-on time, minimizing human error, and increasing sample throughput. Robotic liquid handling systems and microfluidic platforms are streamlining the preparation process, making high-throughput sequencing more accessible to clinical and research laboratories. The development of transposase-based library preparation methods, such as Illumina’s Nextera technology, is simplifying DNA fragmentation and adapter insertion, reducing preparation time and reagent costs. Additionally, single-tube and direct RNA sequencing approaches are eliminating the need for complex workflows, improving efficiency in transcriptomics studies. Advances in molecular barcoding and unique molecular identifiers (UMIs) are enhancing sequencing accuracy by reducing PCR bias and detecting low-frequency variants. The integration of AI and machine learning in bioinformatics is also optimizing library preparation protocols by predicting optimal reagent conditions and improving data interpretation. As these innovations continue to evolve, the NGS library preparation market is poised for greater efficiency, scalability, and clinical adoption.What Is Driving the Growth of the NGS Library Preparation Market?
The growth in the next-generation sequencing library preparation market is driven by several factors, including increasing demand for personalized medicine, expanding applications of NGS in disease research, and technological advancements in automation and reagent chemistry. The growing adoption of NGS-based diagnostics in oncology, infectious diseases, and rare genetic disorders is fueling demand for more efficient and cost-effective library preparation solutions. The rise of single-cell sequencing is also contributing to market growth, as researchers require specialized library preparation methods to analyze individual cells with high sensitivity. Additionally, the expansion of agricultural genomics, microbiome studies, and synthetic biology is further driving market demand, as these fields rely on high-throughput sequencing for genomic analysis. The push for standardization and regulatory approvals for clinical NGS applications is also shaping market trends, with manufacturers developing compliant library preparation kits that meet stringent diagnostic requirements. Investments in bioinformatics and cloud-based sequencing platforms are enhancing data management and accessibility, making NGS more widely available for diverse research and clinical applications. As advancements in sequencing technologies continue to lower costs and improve accuracy, the NGS library preparation market is expected to witness sustained growth, revolutionizing genomic research and precision medicine.Report Scope
The report analyzes the Next-generation Sequencing Library Preparation market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.Segments: Sequencing Type (Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Other Sequencing Types); Product Type (Library Preparation Reagents & Consumables, Library Preparation Instruments); Application (Drug & Biomarker Discovery Application, Disease Diagnostics Application, Cancer Diagnostics Application, Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications); End-Use (Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use, Other End-Uses)
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Targeted Genome Sequencing segment, which is expected to reach US$1.4 Billion by 2030 with a CAGR of a 10.4%. The Whole Genome Sequencing segment is also set to grow at 15.8% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $503.5 Million in 2024, and China, forecasted to grow at an impressive 12.8% CAGR to reach $638.2 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Next-generation Sequencing Library Preparation Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Next-generation Sequencing Library Preparation Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Next-generation Sequencing Library Preparation Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Agilent Technologies, Inc., Alida Biosciences, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories, Inc. and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 48 Featured):
- Agilent Technologies, Inc.
- Alida Biosciences, Inc.
- Beckman Coulter, Inc.
- Becton, Dickinson and Company (BD)
- Bio-Rad Laboratories, Inc.
- CD Genomics
- Claret Bioscience LLC
- F. Hoffmann-La Roche AG
- Fluidigm Corporation
- Hamilton Company
- Illumina, Inc.
- New England Biolabs Inc.
- Oxford Nanopore Technologies Ltd.
- Pacific Biosciences of California, Inc.
- PerkinElmer, Inc.
- QIAGEN N.V.
- Swift Biosciences Inc.
- Takara Bio Inc.
- Tecan Group Ltd.
- Thermo Fisher Scientific Inc.
Tariff Impact Analysis: Key Insights for 2025
Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
What’s Included in This Edition:
- Tariff-adjusted market forecasts by region and segment
- Analysis of cost and supply chain implications by sourcing and trade exposure
- Strategic insights into geographic shifts
Buyers receive a free July 2025 update with:
- Finalized tariff impacts and new trade agreement effects
- Updated projections reflecting global sourcing and cost shifts
- Expanded country-specific coverage across the industry
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies, Inc.
- Alida Biosciences, Inc.
- Beckman Coulter, Inc.
- Becton, Dickinson and Company (BD)
- Bio-Rad Laboratories, Inc.
- CD Genomics
- Claret Bioscience LLC
- F. Hoffmann-La Roche AG
- Fluidigm Corporation
- Hamilton Company
- Illumina, Inc.
- New England Biolabs Inc.
- Oxford Nanopore Technologies Ltd.
- Pacific Biosciences of California, Inc.
- PerkinElmer, Inc.
- QIAGEN N.V.
- Swift Biosciences Inc.
- Takara Bio Inc.
- Tecan Group Ltd.
- Thermo Fisher Scientific Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 220 |
Published | April 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 1.9 Billion |
Forecasted Market Value ( USD | $ 4.1 Billion |
Compound Annual Growth Rate | 13.4% |
Regions Covered | Global |